Crinetics Pharmaceuticals (NasdaqGS:CRNX) FY Conference Transcript

Crinetics Pharmaceuticals (NasdaqGS:CRNX) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsScott Struthers - CEOIsabel Kalofonos - Chief Commercial OfficerTobin Schilke - CFOConference Call ParticipantsJessica Fye - BioTech AnalystJessica FyeGreat. Good morning. Welcome. My name's Jess Fye. I'm a biotech analyst at J.P. Morgan, and we're continuing the 44th Annual Healthcare Conference today with Crinetics. You're going to hear a presentation from the management team, and then we're going to g ...